N/A
Completed N=50
Development of Method of Fructose Identification in Urine to Detect the Viral Infection
Source: ClinicalTrials.gov NCT01638312 ↗Enrolled (actual)
50
Serious AEs
—
Results posted
Oct 2015
Primary outcomePrimary: Fructose Identification in Urine to Detect the Viral Infection : Number of Participants With Positive and Negative Waveform — 12; 7; 8; 23 participants
Summary
The goal of this research is the attempt to implement a new research method based on modern electrochemistry successes, in particular the development of the polarographic method of fructose and fructose diphosphate identification and its implementation to detect the viral infection in early stage. There will be 20 samples from the HIV-infected patients and 30 samples from the heath controls. The study will collect 10ml urine and examined fructose and fructose-diphosphate using the polarographic method.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Fructose Identification in Urine to Detect the Viral Infection : Number of Participants With Positive and Negative Waveform |
12; 7; 8; 23 | — |
Eligibility Criteria
Inclusion Criteria
- HIV infection
Exclusion Criteria
- who are in highly active antiretroviral therapy(HARRT) therapy
Data sourced from ClinicalTrials.gov (NCT01638312). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.